Vivo Bio Tech
27.99
+0.16(+0.57%)
Market Cap₹62.16 Cr
PE Ratio13.64
IndustryHealthcare
Company Performance:
1D+0.57%
1M+21.64%
6M-15.84%
1Y-28.60%
5Y-53.93%
View Company Insightsright
More news about Vivo Bio Tech
20Aug 25
Vivo Bio Tech Secures ₹10.75 Crore Pre-Clinical Testing Contract for Novel Molecule
Vivo Bio Tech Limited has secured a pre-clinical testing contract worth ₹10.75 crores with a leading Indian pharmaceutical and agro-chemical company. The two-year contract involves comprehensive pre-clinical safety and regulatory studies for a novel molecule, including toxicity, mutagenicity, ecotoxicology studies, and analytical services. The studies will be conducted under Section 9(3) requirements for submission to the Central Insecticides Board & Registration Committee (CIBRC). This contract positions Vivo Bio Tech among top Contract Research Organizations in India, demonstrating its capability to deliver integrated pre-clinical solutions meeting national and international regulatory standards.
 no imag found
14Aug 25
Vivo Bio Tech Reports Strong Q1 FY2026 Performance with 29.66% Revenue Growth
Vivo Bio Tech Limited announced robust Q1 FY2026 results. Total income increased by 29.66% to Rs. 2,220.72 lakhs. Profit After Tax rose by 21.93% to Rs. 155.72 lakhs. Earnings Per Share improved to Rs. 1.05. Operating Profit Margin increased to 9.04%. The company published its un-audited financial results in English and Telugu newspapers on August 14, 2025.
 no imag found
04Aug 25
Vivo Bio Tech Shareholders Approve Increase in Authorized Share Capital
Vivo Bio Tech Limited secured shareholder approval to increase its authorized share capital and alter the Capital Clause of its Memorandum of Association. The resolution passed with 99.81% votes in favor, with a 31.47% overall participation rate. The Promoter and Promoter Group showed 100% support with a 68.78% participation rate. This approval could enable the company to raise additional funds, potentially for growth strategies or expansion plans.
 no imag found
Vivo Bio Tech
27.99
+0.16
(+0.57%)
1 Year Returns:-28.60%
Industry Peers
Anthem Biosciences
760.10
(-1.95%)
Advanced Enzyme Tech
347.70
(+2.95%)
CCME Global
111.95
(+4.63%)
Vivo Bio Tech
27.99
(+0.57%)